MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
Michaël H. Meel(Princess Máxima Center), Esther Hulleman(Amsterdam UMC Location VUmc)
Cited by 39
Related Papers
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|136
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
|Clinical Cancer Research|2020|63
MELK Inhibition in Diffuse Intrinsic Pontine Glioma
|Clinical Cancer Research|2018|45